Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...
Recent viral mutations have shown avian influenza’s adaptability to mammalian hosts, prompting infectious disease, animal ...
Research from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago strongly ...
While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...
The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.
Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results